VIR BIOTECHNOLOGY INC
VIRNASDAQ🏆 #1911 by market capEarnings Nov 4 · PostUS Equity
$11.75▼ $0.19 (−1.59%)
🌙 After hours$11.94▲ 1.62%Regular close · extended-hours price shownTrack VIR
Get earnings, price moves & breaking news on Telegram
24h▼ 1.6%
7d▲ 11.2%
14d▲ 17.9%
30d▲ 5.3%
ytd▲ 95.2%
1y▲ 98.5%
🏦Market Cap
$1.99B
Small Cap
📈Revenue Growth (YoY)
-7.6%
Declining
📊Gross Margin
96.2%
High
💵FCF Margin
-65.5%
Thin
⚖️P/S Ratio
6.6x
Fair
Otter Score
68
Fair
VIR BIOTECHNOLOGY INC
VIRAnalyst Ratings
Price
$11.75
Total
12
Raised
2
Lowered
0
Avg PT
$23.50
H / L
$25 / $22
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-10-07 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-06-11 | $25.00 | +112.80% |
Leerink Partners | Reiterated | Outperform | 2026-06-03 | $20.00 | +70.20% |
Barclays | Reiterated | Overweight | 2026-02-25 | $30.00 | +155.30% |
Evercore ISI Group | Reiterated | Outperform | 2026-02-24 | — | — |
Needham | Reiterated | Buy | 2026-02-24 | $18.00 | +53.20% |
B of A Securities | Upgraded | Neutral → Buy | 2025-08-27 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-17 | $28.38 | +141.50% |
JP Morgan | Reiterated | Neutral | 2025-01-09 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-27 | — | — |
Baird | Upgraded | Underperform → Neutral | 2022-03-03 | — | — |
Cowen & Co. | Reiterated | Outperform | 2019-11-05 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-10-07
—
—
Morgan Stanley
Reiterated · Overweight · 2026-06-11
$25.00
+112.80%
Leerink Partners
Reiterated · Outperform · 2026-06-03
$20.00
+70.20%
Barclays
Reiterated · Overweight · 2026-02-25
$30.00
+155.30%
Evercore ISI Group
Reiterated · Outperform · 2026-02-24
—
—
Needham
Reiterated · Buy · 2026-02-24
$18.00
+53.20%
B of A Securities
Upgraded · Neutral → Buy · 2025-08-27
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-17
$28.38
+141.50%
JP Morgan
Reiterated · Neutral · 2025-01-09
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-27
—
—
Baird
Upgraded · Underperform → Neutral · 2022-03-03
—
—
Cowen & Co.
Reiterated · Outperform · 2019-11-05
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space